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Highlights 
• Oscillatory but not laminar shear stress reduces endothelial glycocalyx sialic acid 
• Laminar shear stress activates Nrf2-regulated endogenous antioxidant defences 
• Disruption of sialic acids attenuates Nrf2 activation by laminar shear stress 
• Knockdown of endogenous sialidase NEU1 enhances Nrf2 responses to flow  



























Redox Biology - Accepted Version 25-11-20 
Abstract 
Activation of the nuclear factor erythroid 2–related factor 2 (Nrf2) pathway is critical for vascular 
endothelial redox homeostasis in regions of high, unidirectional shear stress (USS), however the underlying 
mechanosensitive mediators are not fully understood. The endothelial glycocalyx is disrupted in arterial 
areas exposed to disturbed blood flow that also exhibit enhanced oxidative stress leading to atherogenesis. 
We investigated the contribution of glycocalyx sialic acids (SIA) to Nrf2 signaling in human endothelial 
cells (EC) exposed to atheroprotective USS or atherogenic low oscillatory shear stress (OSS). Cells exposed 
to USS exhibited a thicker glycocalyx and enhanced turnover of SIA which was reduced in cells cultured 
under OSS. Physiological USS, but not disturbed OSS, enhanced Nrf2-mediated expression of antioxidant 
enzymes, which was attenuated following SIA cleavage with exogenous neuraminidase. SIA removal 
disrupted kinase signaling involved in the nuclear accumulation of Nrf2 elicited by USS and promoted 
mitochondrial reactive oxygen species accumulation. Notably, knockdown of the endogenous sialidase 
NEU1 potentiated Nrf2 target gene expression, directly implicating SIA in regulation of Nrf2 signaling by 
USS. In the absence of SIA, deficits in Nrf2 responses to physiological flow were also associated with a 
pro-inflammatory EC phenotype. This study demonstrates that the glycocalyx modulates endothelial redox 
state in response to shear stress and provides the first evidence of an atheroprotective synergism between 
SIA and Nrf2 antioxidant signaling. The endothelial glycocalyx therefore represents a potential therapeutic 
target against EC dysfunction in cardiovascular disease and redox dyshomeostasis in ageing. 
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USS, unidirectional shear stress; VCAM-1, vascular cell adhesion molecule-1. 
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1. Introduction 
Vascular endothelial cell defences against oxidative stress are coordinated by the transcription factor Nrf2, 
which modulates antioxidant gene expression through binding to DNA sequences termed antioxidant 
response elements (ARE) [1]. Under basal conditions, proteasomal degradation of constitutively 
synthesised Nrf2 is mediated by its cytosolic redox-sensitive partner Kelch-like ECH-associated protein 1 
(Keap-1) [2]. Cytotoxic insults such as electrophiles and xenobiotics disrupt this interaction [3, 4], allowing 
Nrf2 to accumulate in the nucleus where it promotes the transcription of genes encoding antioxidant, phase 
II detoxifying and glutathione synthesising enzymes to restore redox balance [5].  
 
As reviewed previously [6], endothelial Nrf2 signaling is promoted by high unidirectional shear stress 
(USS) [7], whereas arterial regions exposed to low oscillatory shear stress (OSS) are prone to atherogenesis, 
partly due to diminished endothelial nitric oxide synthase (eNOS) expression [8] and attenuated antioxidant 
and anti-inflammatory properties of Nrf2 activation [9]. Exposure of EC to USS has been shown to promote 
Nrf2-dependent induction of cytoprotective genes [10], due to oxidation of thiol groups on Keap-1 [11] by 
cellular sources of reactive oxygen species (ROS)  [12, 13]. Activation of the Nrf2 pathway by USS can  
also be mediated by kinase signaling events [14, 15] and is primed by shear-sensitive expression of Krüppel-
like factor 2 (Klf2) [16], responsible for transcriptional programing of endothelial atheroprotection [17]. In 
contrast, Nrf2 stabilization and nuclear translocation in response to OSS does not promote ARE-dependent 
gene transcription [12] due to additional epigenetic regulation by histone deacetylases and mechano-
sensitive microRNAs [6].   
 
Despite the pivotal role of shear-sensitive Nrf2 regulation in determining susceptibility to vascular disease, 
the biomechanical mediators of this effect remain to be fully elucidated. Various plasma membrane 
molecules, microdomains and cytoskeletal components participate in shear stress mechano-sensation and 
transduction [18]. In particular, the glycocalyx (GCX), comprised of glycoproteins, proteoglycans, 
glycosaminoglycans (GAG) and glycolipids, has dimensions and biochemical composition that dependent 
on the dynamic equilibrium between its biosynthesis, degradation and local shear stress profiles [19]. The 
GCX contributes to the regulation of vascular tone via its mechanotransduction properties and is critical for 
blood rheology in the microcirculation, molecular filtration across the vascular wall, as well as 
thromboresistance and immuno-modulation  [20]. Sialic acid (SIA) monosaccharides occupy the terminal 
branches of glycan chains within the GCX of EC, blood cells and common pathogens [21]. Arterial 
segments exposed to disturbed shear stress exhibit SIA deterioration, which predisposes them to 
atherogenesis [22]. Diminished SIA in the endothelial GCX is also associated with an enhanced risk of 
vascular dysfunction in diabetes [23] and is observed in rodent models of ageing [24]. Notably, EC 
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desialylation by exogenous sialidases has been shown to impair NO-dependent vasodilatation by shear 
stress [25] due to enhanced ROS generation [26]; however the contribution of SIA in shear mediated 
induction of endogenous antioxidant defences remains to be elucidated.  
 
In this study, we report the first evidence that fluid shear stress regulates EC redox signaling via alterations 
in the SIA component of the GCX. Using primary human EC, we demonstrate differential SIA expression 
and Nrf2-mediated antioxidant responses to USS and OSS. Furthermore, cleavage of SIA by exogenous 
neuraminidase led to diminished USS-mediated Nrf2 activation and an enhanced pro-inflammatory EC 
phenotype. In contrast, silencing of endogenous sialidase NEU1 enhanced Nrf2 responses to flow, 
highlighting the shear-sensitive crosstalk between SIA and endogenous antioxidant defences. Our findings 
demonstrate that OSS-mediated SIA modifications lead to diminished activation of atheroprotective Nrf2 
signaling, suggesting that GCX could be a key therapeutic target not only for age-related cardiovascular 
disease (CVD) but also infectious diseases, cancer and diabetes. 
2. Materials and Methods 
2.1. Materials and reagents 
Neuraminidase from Clostridium perfringens (C. welchii) and β-actin antibody were obtained from 
Millipore-Sigma (Burlington, MA, USA). CF™488A-WGA and CFTM568A-PNA lectins were from 
Biotium Inc. (Hayward, CA, USA), heparan sulfate (HS) epitope 10E4 antibody was from AMS 
Biotechnology (Abingdon, UK) and HO-1 antibody from BD Biosciences (San Jose, CA, USA). Nrf2, 
eNOS, NQO1, Klf2 and Klf4 antibodies as well as polybrene and puromycin were obtained from Santa 
Cruz Biotechnology Inc. (Dallas, TX, USA). Phospho-Nrf2 (S40), VCAM-1, NFkB (p65) and all 
AlexaFluor® secondary antibodies were from Abcam (Cambridge, UK). GCLM antibody was a kind gift of 
Prof. Terrance Kavanagh (University of Washington, Seattle). Phospho-GSK3β (Y216) and total GSK3β, 
phospho-eNOS (S1177 and S633), phospho-protein kinase B (Akt, S473) and total Akt antibodies were 
from Cell Signaling Technology (Danvers, MA, USA). Enhanced chemiluminescence reagents (ECL) were 
from GE Healthcare Life Science (Amersham, UK). All other chemicals, reagents and tissue culture 
supplies were purchased from Millipore-Sigma (Burlington, MA, USA). 
2.2. Endothelial cell isolation and culture 
Umbilical cords from healthy, full-term pregnancies were obtained from the Maternity Unit at St. Thomas’ 
Hospital (London, UK) with informed participant consent and Research Ethics Committee approval 
(Ref:15/EM/0290). Human umbilical vein endothelial cells (HUVEC) were isolated within 2 days of 
delivery using collagenase digestion as previously described [27]. Cells were cultured in gelatin-coated 
Redox Biology - Accepted Version 25-11-20 
flasks in Medium 199 (M199) containing 10% (v/v) fetal and 10% (v/v) neonatal calf serum, NaHCO3 
(18mmol L-1), penicillin/streptomycin (119 U ml-1/120 μg ml-1), L-glutamine (5mmol L-1) and endothelial 
cell growth supplement (ECGS, 5ng ml-1) in a 5% CO2/95% humidified air incubator at 37°C. EC 
monolayers were passaged with trypsin and all experiments were performed at passage 3. The HUVEC-
derived endothelial cell line EA.hy926 (gifted by Unilever UK) [28] was used for infection with lentiviral 
vectors and maintained under the same conditions as HUVEC.  
2.3. Fluid shear stress application 
The Ibidi parallel-plate flow system (Ibidi GmbH, Germany) was used to recapitulate the laminar and 
oscillatory shear stress profiles associated with anti- and pro-atherogenic EC phenotypes, respectively. As 
the endothelial glycocalyx is established upon reaching quiescence [29],  EC seeded in μ-I0.6 Luer slides 
were maintained in static culture for 48 hours to allow sufficient GCX growth. Cell monolayers were then 
exposed to shear stress (τ, dynes cm-2), calculated using the formula τ= μ 60.1 Φ. τ is proportional to the 
dynamic viscosity of the medium μ (0.00782 dynes s cm-2 for M199 at 37°C [30]) and the flow rate Φ (ml 
min-1) generated by the air pressure pump. Cells were preconditioned to two consecutive 30 min cycles of 
2 and 5 dynes cm-2 of unidirectional flow (USS), followed by either disturbed flow of ±5 dynes cm-2 where 
the direction reverses periodically (OSS, 1Hz oscillations) or USS of 15 dynes cm-2, each for the indicated 
experimental periods. All cells were incubated in M199 without ECGS (basal M199) for 12 hours before 
and during shear stress application. 
2.4. Transmission Electron Microscopy (TEM) 
Changes in GCX size and organisation were assessed by TEM at the Centre for Ultrastructural Imaging 
(King’s College London). To preserve GCX integrity HUVEC were cultured on the detachable bottom of 
an Ibidi sticky slide μ-I0.6 Luer and were perfused with two lysine-acetate solutions; the first containing 2% 
glutaraldehyde and 0.08% Alcian Blue (AB), followed by one containing 2% paraformaldehyde, 2.5% 
glutaraldehyde and 0.075% Ruthenium Red (RR). AB, RR and lysine are cationic reagents with high 
affinity for the negatively charged GCX [31]. Samples were osmicated (1% OsO4) and dehydrated in a 
graded ethanol series before embedding in epoxy resin. Ultrathin (70-90 nm) sagittal sections obtained with 
a Leica UC7 ultramicrotome were mounted on 150 μm mesh copper grids and double-contrasted in 
UranyLess and 3% lead citrate (Electron Microscopy Sciences, UK) before examination under a JEM-
1400Plus microscope (JEOL). High power electron micrographs of at least 10 different cells per condition 
were analysed using FIJI software [32]. Twenty measurements were collected from each cell, at points 
where both phospholipid bilayers were visible to ensure that luminal GCX depth was measured 
perpendicular to the plasma membrane [33]. GCX thickness was determined as half the maximal pixel 
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intensity of the distance between the luminal edge and the lipid bilayer. Occasionally strands extending up 
to 200 nm were visible that were not included in the quantification process. 
2.5. SIA cleavage and staining 
SIA removal was achieved enzymatically using neuraminidase from C. perfringens as described previously 
[34]. EC were incubated in basal M199 lacking all serum that contained 2U ml-1 neuraminidase (Sigma 
units) for 30 min at 37°C. Cells were then either returned to basal M199 for further experimentation or 
fixed with 4% paraformaldehyde (PFA) for 10 min. Subsequently, cells were blocked with 4% bovine 
serum albumin (BSA) at room temperature (RT, 1 h) and stained with wheat germ agglutinin (WGA) 
conjugated to a green fluorescent dye (CF™488A, excitation/emission: 490/515 nm, 2μg ml-1, 30 min). Cell 
nuclei were stained with 4, 6-diamidino-2-phenylindole dihydro chloride (DAPI, 2μg ml-1) and samples 
were preserved in mounting media (Ibidi GmbH, Germany) until imaged. 
WGA images (2048 x 2048 pixels) were acquired with LSM-780 confocal laser scanning microscope 
(AxioObserver.z1, Carl Zeiss GmbH, Germany) using an oil immersion objective (Zeiss, Plan-Apochromat 
x40/1.3 NA). WGA-CFTM448A and DAPI were excited with Argon (458/488/514 nm, 25 mW) and diode 
(405 nm, 30 mW) lasers, respectively. For some experiments, planar sections were obtained along the z-
axis (0.1 μm apart) and reconstructed into orthogonal views with FIJI software which was also used for 
false coloring and image analysis. For some experiments, SIA and DAPI were visualized with an 
epifluorescence microscope as described below. The mean fluorescence intensity of background subtracted 
fields of view (FOV) was normalized to the respective number of cell nuclei and expressed as mean cell 
intensity (MCI) of at least 300 cells per experimental condition. 
2.6. Determination of free SIA 
The total amount of free SIA was determined enzymatically using the NANA Assay kit (Abcam, 
Cambridge, UK) according to the manufacturer’s protocol. Briefly, conditioned cell culture medium was 
centrifuged (1500 rpm, 5 min) and equal volumes of sample or assay standard were allowed to react (RT, 
30 min) with the Oxi-Red probe that relies on free SIA oxidation to give fluorescence at 
excitation/emission:535/587 nm that was measured with a plate reader (ClarioStar; BMG Labtech, 
Germany). The concentration of free SIA was normalized to the original sample volume.  
2.7. RT-qPCR 
The mirVanaTM miRNA isolation kit (Ambion, Thermo Fisher Scientific) was used to extract total RNA 
which was reverse transcribed in equal amounts (300 ng) with the high capacity cDNA kit (Applied 
BiosystemsTM, Thermo Fisher Scientific). Gene expression was determined with SYBR® green I 
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(SensimixTM No-ROX kit, Bioline) using specific primer pairs (Table 1) and amplified by Rotor-GeneTM 
6000 thermal cycler (Corbett Research, UK). Target gene levels were interpolated by a standard curve of 
known copy number concentrations and normalized to the geometric mean of five reference genes using 
geNorm algorithm [35] (Table1).  
2.8. Immunoblotting 
Whole-cell protein was extracted with a sodium dodecyl sulfate lysis buffer (2% w/v) containing protease 
and phosphatase inhibitors. Total protein content was determined with the bicinchoninic acid assay (Pierce, 
Thermo Fisher Scientific) before separation of equal amounts of denatured protein by gel electrophoresis 
and transfer to PVDF membranes. Non-specific binding sites were blocked with 5% w/v skimmed milk 
before overnight incubation (4°C) with primary antibodies raised against proteins of interest or β-actin that 
was used as a loading control. Protein expression was detected with horseradish peroxidase-conjugated 
secondary antibodies and countered by ECL reagents. Immunoblots were visualized with the G-box gel 
documentation system (Syngene Bioimaging) and band densitometric analysis was carried out with FIJI 
software. 
2.9. Lentiviral gene transfection 
EA.hy926 cells were infected at multiplicity of infection of 10 (48 h) with lentiviral particles containing 
anti-Nrf2, anti-NEU1 or non-target (scrambled) shRNA and puromycin resistance genes (Santa Cruz 
Biotechnology). Transfection efficiency was enhanced with of polybrene (5 μg ml-1) and following 72-hour 
recovery in antibiotic-free M199, stably transduced cells were identified by puromycin (2 μg ml-1) selection. 
Antibiotic-resistant cell populations were expanded over two weeks in the continuous presence of 
puromycin, which was removed 48 hours before experimentation. 
2.10. Nrf2 and NFkB immunocytochemistry 
Fixed cells were permeabilized with TritonX-100 (0.1%, 10 min) and blocked with 4% BSA. Cellular 
localization of Nrf2 or the p65 (Rel-A) subunit of NFkB was examined by specific primary (overnight, 
4°C) and AlexaFluor® 488 and 555 secondary antibodies (1h at RT), respectively. Immunofluorescence 
images were acquired with a water immersion objective (Olympus, LUMPlanFL x40/0.8 NA) of an inverted 
epifluorescence microscope (Nikon Diaphot) fitted with a Nikon DXM1200F digital camera. Nuclear and 
cytoplasmic fluorescence intensity were quantified and background corrected using FIJI software.  
2.11. Detection of mitochondrial ROS 
At the end of each experimental protocol, cells were loaded with the dihydroethidium-conjugated 
fluorogenic probe MitoSOXTMRed (excitation/emission: 510/580 nm, Invitrogen) prepared in serum-free 
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M199 (5 μΜ). Incubation for 30 min under static conditions was followed by fixation with 4% PFA and 
nuclei staining with DAPI before imaging with an inverted epifluorescence microscope as described above. 
FIJI software was used to quantify and background correct the mean fluorescence intensity that was 
normalized to the number of cell nuclei per FOV. 
2.12. Statistics 
Data denote mean ± S.E.M. from experiments of at least 3 different HUVEC donors or 3 independent 
EA.hy926 cultures, unless otherwise stated. Statistical comparisons between two independent groups were 
performed with unpaired Student’s t-test while one- or two-way ANOVA with Tukey or Bonferroni post 
hoc tests were used to evaluate statistical differences between more than two conditions. P values <0.05 
were considered statistically significant.  
3. Results 
3.1. Laminar flow enhances luminal GCX expression in vitro 
Although HUVEC maintained in culture have diminished GCX thickness compared to the umbilical vein 
in vivo [36], multiple studies have demonstrated the vasoprotective properties of the GCX in vitro. Since 
static culture does not represent the dynamic conditions developed in the vasculature, we exposed HUVEC 
to laminar flow to more accurately recapitulate the physiological GCX environment. As revealed by TEM, 
HUVEC maintained in static culture have a rudimentary GCX, which becomes more uniform and thicker 
after prolonged exposure to USS (Fig. 1A). SIA is a major component of the vascular GCX and is markedly 
reduced in atheroprone regions of the vasculature exposed to disturbed shear stress profiles [37]. Given the 
abundance of SIA in the human umbilical vein [38], we next assessed its expression using WGA lectin 
labelling. Consistent with previous studies, static cells had abundant SIA expression at different passages 
(p0 to p3, data not shown) and while application of USS enhanced SIA levels (Fig. 1B), WGA intensity 
was diminished in cells exposed to OSS. In line with the TEM findings above, the 3-dimensional volume 
views of the confocal reconstructions, demonstrated enhanced apical localization of WGA staining in 
response to laminar flow (Fig. S1), however, that was not observed under static or OSS conditions.  
To ascertain whether shear stress-modulation of WGA binding is due to altered SIA expression and not a 
consequence of stereochemical changes affecting their interaction [39], the free SIA content of the 
conditioned culture medium was investigated. Free SIA was accumulated in the culture medium of cells 
exposed to USS relative to OSS or static culture (Fig. 1C). Because glycan sialylation depends on the 
balance between SIA biosynthesis and the opposing actions of endogenous sialyltransferases and sialidases, 
the transcription of genes encoding enzymes involved in SIA metabolism was also assessed (Fig. 1D). 
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mRNA levels of the rate-limiting SIA biosynthetic enzyme glucosamine (UDP-N-acetyl)-2-epimerase/N-
acetylmannosamine kinase 1 (GNE) [40] paralleled the differential SIA expression in response to USS and 
OSS. In contrast, only OSS enhanced mRNA expression of the nuclear enzyme cytidine monophosphate 
N-acetylneuraminic acid synthetase (CMAS) which generates SIA and nucleotide sugar pairs [41]. These 
are subsequently transported into the Golgi via the SLC35A1 antiporter [42] that was here reduced at 
mRNA level in response to OSS. Consistent with previous reports [43], the endogenous sialidase NEU1, 
which hydrolyses terminal SIA from the adjacent glycans, was the most abundant isoform expressed in 
HUVEC (data not shown). NEU1 mRNA was enhanced under flow conditions (Fig. 1D), but to a 
significantly greater extent by disturbed rather than laminar flow. These observations highlight that SIA 
remodelling is particularly susceptible to variations in shear stress and thus may regulate mechano-sensitive 
signaling.   
3.2. OSS and SIA disruption attenuate antioxidant Nrf2 signaling activation by physiological flow 
One of the most characterized Nrf2 targets is heme oxygenase-1 (HO-1), a stress response enzyme 
transcriptionally upregulated to confer protection against oxidative damage [5]. Physiological shear stress 
is a potent inducer of HO-1 expression, which is diminished in vascular areas susceptible to atherosclerosis 
and cells exposed to disturbed flow [7, 9]. In line with these studies, HO-1 was upregulated in HUVEC 
exposed to flow, but the response to physiological USS was significantly greater (Fig. 2A). Under these 
conditions, similar results were obtained for the Nrf2-regulated detoxifying enzyme NAD(P)H quinone 1 
oxidoreductase 1 (NQO1) and the modifier subunit of glutamate cysteine ligase (GCLM) required for 
biosynthesis of glutathione (Fig. S2A). Flow-mediated changes in antioxidant enzyme expression were also 
associated with increased Nrf2 nuclear localization in response to USS compared to OSS and static culture 
(Fig. S2B). To confirm that upregulation of these antioxidant enzymes is Nrf2 dependent, lentiviral 
silencing of Nrf2 was achieved in the shear-responsive EA.hy926 endothelial cell line which abolished USS 
upregulation of total Nrf2 protein levels (Fig. S2C). USS-mediated induction of HO-1 protein expression 
was also abrogated in Nrf2 knockdown cells (Fig. 2B), and this was replicated for NQO1 and GCLM 
expression (Fig. S2C) and with shorter exposure to USS (data not shown). 
Our study established a similar temporal regulation of the Nrf2/ARE pathway and SIA expression within 
the same 48-hour period of shear stress conditioning. As enzymatic removal of SIA enhances ROS 
production [26], we next investigated whether this is due to mechanosensitive modulation of the Nrf2/ARE 
pathway. To selectively remove the SIA component of the GCX, cells were treated with 2U ml-1 
neuraminidase (Fig. 2C and Fig. S3) for a short period of time (30 min) to avoid the observed time- and 
dose-dependent decline in cell viability (data not shown). As GCX regrowth is a dynamic process with 
distinct recovery timeline for different components [44] and is enhanced in response to physiological flow 
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[45], control and neuraminidase-treated cultures were subjected to USS for different times. Cell exposure 
to USS enhanced WGA staining at 24 hours compared to 8 hours in both treatment conditions (Fig. 2C). 
Neuraminidase significantly decreased WGA staining for at least 8 hours post treatment, but significant 
SIA restoration was observed after 24 hours (Fig. 2C). To avoid cytotoxicity caused by continuous exposure 
to neuraminidase, we used the acute SIA recovery period (<8 hours) to assess its role in Nrf2 signaling. 
SIA removal with neuraminidase attenuated the induction of HO-1, NQO1 and GCLM protein levels in 
response to 6 hours of USS (Fig. 2D). After 24 hours, however, the induction of these enzymes by laminar 
shear stress was restored, concomitant with regrowth of SIA. Notably, treatment with neuraminidase under 
static conditions did not affect antioxidant enzyme expression at similar time points assessed (data not 
shown). 
3.3. SIA removal impairs Nrf2 nuclear accumulation in response to physiological flow 
We next investigated the mechanisms by which SIA regulate Nrf2 signaling. USS stabilises newly 
synthesised Nrf2 protein and enhances its nuclear accumulation [10, 13], which we observed after 4 hours 
of USS application (Fig. 3A).  SIA removal with neuraminidase significantly reduced nuclear Nrf2 levels 
in cells exposed to USS (Fig. 3A). Moreover, neuraminidase attenuated USS-induced phosphorylation of 
Nrf2-Ser40 (Fig. 3B), previously shown to reduce Nrf2 association with Keap-1 in cells maintained in static 
culture [46]. In response to physiological flow the latter mechanism is mediated by protein kinase B (Akt) 
activity [7]. Indeed, acute exposure of HUVEC to USS stimulated Akt phosphorylation, which was 
significantly reduced following SIA cleavage with neuraminidase (Fig. 3C). Activation of the 
phosphoinositide 3-kinase (PI3K)–Akt pathway can further promote Nrf2 activity via inhibition of 
glycogen synthase kinase 3β (GSK3β) [47]. When HUVEC were treated with neuraminidase prior to USS 
exposure, phosphorylation of GSK3β at Tyr216 was increased (Fig. 3D). 
3.4. NEU1 knockdown promotes Nrf2 activation by physiological flow 
To further investigate the role of SIA in shear stress mediated modulation of Nrf2 signaling, we silenced 
the endogenous sialidase NEU1. In EA.hy926 cells transduced with control shRNA, OSS enhanced NEU1 
protein expression to a greater extent than USS, while flow conditioning of NEU1 knockdown cells did not 
alter sialidase levels compared to static culture (Fig. 4A). As NEU1 expression was previously associated 
with cell surface desialylation [48], we next assessed the effects of NEU1 silencing on SIA levels. NEU1 
knockdown significantly enhanced SIA immunofluorescence in cells exposed to USS (Fig. 4B) and SIA 
levels were attenuated by disturbed compared to laminar flow. Moreover, enhanced SIA expression in the 
absence of NEU1 was associated with upregulation of Nrf2 target enzymes HO-1, NQO1 and GCLM in 
response to USS (Fig. 4C). Taken together, our findings suggest that SIA disruption reduces 
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mechanosensitive activation of endogenous antioxidant systems by Nrf2 which is key for EC adaptation to 
oxidative stress in regions of high shear stress and may thus elicit dysfunctional EC phenotypes, 
investigated next.  
3.5. Disturbed flow and SIA cleavage enhance mitochondrial ROS levels 
Mitochondrial free radicals are important mechanosensitive secondary messengers responsible for 
inducible expression of Nrf2 targets in response to  physiological flow [13, 49]. However, mitochondrial 
ROS generation in response to disturbed flow is pro-apoptotic [50] and may contribute to EC-originated 
atherogenesis. Here, we observed enhanced levels of mitochondrial ROS in HUVEC exposed to prolonged 
OSS compared to laminar flow or with culture under static conditions (Fig. 5A). SIA removal with 
neuraminidase increased MitoSOX Red fluorescence in response to acute USS exposure (Fig. 5B) and a 
similar, albeit not statistically significant trend was observed in static cultures.  
3.6. SIA removal promotes a pro-atherogenic EC phenotype in response to physiological flow 
Cleavage of SIA from the endothelial GCX also reduces flow-mediated NO bioavailability [51], therefore 
we next examined eNOS expression and phosphorylation following SIA removal. Neuraminidase did not 
affect total eNOS protein levels, however, in cells exposed to USS, SIA cleavage reduced phosphorylation 
of eNOS stimulatory sites Ser 1177 and 633 (Fig. 6A and 6B) which are critical for NO output [52, 53]. 
Moreover, physiological EC function is disrupted in arterial regions susceptible to atherogenesis due to the 
diminished expression of transcription factors Klf2 and Klf4 [54, 55]. The atheroprotective properties of 
Klf2 stimulation are partly mediated by induction of Nrf2 targets [16], therefore we assessed the effects of 
SIA disruption on shear-sensitive Klf2 and Klf4 regulation. Prolonged (24 h) EC exposure to OSS reduced 
Klf2 and Klf4 mRNA levels relative to USS (data not shown). Similarly, SIA cleavage with neuraminidase 
attenuated early induction of both Klf2 and Klf4 by USS which was restored following SIA re-growth at 
24 hours (Fig. S4).  
Deficits in Klf2 and Klf4 expression promote atherosusceptible EC phenotypes partly via upregulation of 
vascular cell adhesion molecule 1 (VCAM-1) [55, 56], and suppression of Nrf2 signaling by disturbed shear 
stress elicits vascular inflammation through similar mechanisms in vivo [9]. As SIA cleavage with 
neuraminidase attenuated USS-mediated Nrf2 responses and protein expression of Klf2 and Klf4, we next 
investigated whether it is also a pro-inflammatory EC stimulus. Prolonged (48 h) HUVEC exposure to 
physiological USS significantly reduced VCAM-1 protein levels compared to OSS and static culture (data 
not shown). Notably, SIA cleavage with neuraminidase enhanced VCAM-1 expression under both static 
and acute USS conditions (Fig. 6C). Nuclear transcription factor-κB (NF-κB) is a key mediator of flow-
sensitive VCAM-1 expression [57] and exhibits a biphasic pattern of initial activation and subsequent 
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inhibition by prolonged laminar flow [58].  In agreement with these studies, acute cell exposure to USS 
increased nuclear translocation of the NF-κB p65 subunit, while SIA removal with neuraminidase further 
enhanced this effect (Fig. 6D) and promoted nuclear translocation of p65 under static conditions. 
4. Discussion 
This study is the first to demonstrate that the SIA component of the glycocalyx acts as a novel shear-
sensitive regulator of endogenous Nrf2-mediated antioxidant defences in human EC. Moreover, we provide 
novel evidence that in the absence of SIA, EC cultured under USS have impaired eNOS phosphorylation, 
enhanced levels of mitochondrial ROS and the proinflammatory marker VCAM-1, thus phenotypically 
resembling EC exposed to pro-atherogenic OSS. Diminished SIA at arterial branch points exposed to 
disturbed flow [37] and, in combination with systemic stressors or risk factors such as age [24], predisposes 
these sites to atherogenesis. To recapitulate the endothelial desialylation that occurs in response to OSS, we 
removed SIA with exogenous neuraminidase, which has been shown to promote neointimal thickening and 
oxidized low density lipoprotein (ox LDL) accumulation in vivo [59], elicit pro-inflammatory responses 
[60] and enhance vascular permeability [61]. Given the wide range of EC homeostatic functions mediated 
by Nrf2 targeted transcription, here we describe a new, potentially anti-atherogenic role for SIA via Nrf2 
signaling.  
Using TEM [62], we demonstrated that USS enhanced the thickness of endothelial GCX in vitro, and 
although additional GCX components may contribute to this effect [63], our findings correlated with 
increased immunofluorescence of surface SIA and transcript levels of its biosynthetic enzyme GNE [40]. 
Studies in animal models have previously shown using TEM a reduced anatomical GCX depth at arterial 
regions exposed to disturbed blood flow patterns [64, 65], which also exhibit reduced WGA staining [37, 
39]. This is consistent with our finding of reduced SIA immunofluorescence in cells exposed to OSS, 
possibly due to deficits in GNE and SLC35A1 transcription afforded by USS, but also via upregulation of 
CMAS, which generates cytosolic SIA-nucleotide donors [66]. The epimerase activity of GNE is tightly 
inhibited by cytosolic levels of the SIA-nucleotide pairs which are normally concentrated into the trans-
Golgi by the SLC35A1 antiporter [42]. Enhanced CMAS transcripts and reduced SLC35A1 expression in 
EC exposed to OSS may therefore rise the cytosolic SIA-nucleotide donor concentration and further impede 
GNE function. Upregulation of DNA-methyltransferases by disturbed flow [67] may also reduce GNE 
transcription via promoter CpG islet hypermethylation [68]. Notably, tissue hyposialylation due to deficits 
in GNE activity leads to age-related neuronal loss [69] and enhances oxidative stress in the skeletal muscle 
of patients with GNE myopathy [70]. Maintenance of surface SIA by shear-sensitive regulation of its 
biosynthesis and degradation is therefore crucial for the regulation of vascular homeostasis.  
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Moreover, the enhanced levels of free SIA we measured in the USS-conditioned culture medium suggested 
increased SIA biosynthesis and turnover as shown previously for the GCX component HS [45]. Serum total 
SIA is elevated following acute myocardial infarction and in patients with type II diabetes and correlates 
with the severity of atherosclerosis [71] and circulating markers of oxidative stress [72]. Notably, SIA is 
susceptible to oxidative cleavage by ROS [73] and oxidative desialylation of plasma proteins such as LDL 
also contributes to the circulating SIA pool [74]. It is possible that enhanced generation or diminished 
scavenging of ROS observed in response to OSS further contributed to reduced expression of SIA. Taken 
together, our results suggest a multifaceted dysregulation of biosynthesis and surface retention of SIA in 
response to OSS.  
The decline in cellular SIA in EC exposed to oscillatory flow was also associated with enhanced expression 
of NEU1. The endogenous sialidase NEU1 resides in two subcellular compartments with distinct 
homeostatic functions; lysosomal NEU1 regulates cytosolic SIA levels by recycling sialoconjugates [75], 
whereas in the plasma membrane it initiates inflammatory cascades via desialylation of surface molecules 
such as ICAM-1 [76] and TLR4 [77]. NEU1-mediated SIA cleavage also inhibits Akt signaling downstream 
of integrin α5β1 [78] and the latter mediates proinflammatory NF-kB activation in response to OSS [79]. 
In the present study, NEU1 silencing enhanced SIA expression in cells exposed to USS but had little effect 
on SIA levels following exposure to OSS, likely due to the sustained deficit in SIA biosynthesis described 
above. Importantly, enhanced SIA expression as a result of NEU1 knockdown upregulated the expression 
of Nrf2 target antioxidant enzymes in response to USS. Pharmacologic or genetic inhibition of NEU1 
activity has been shown to reduce serum cholesterol and alleviate vascular dysfunction that underlies 
atherogenesis in the ApoE-/- mouse [48, 80]. This suggests that shear-sensitive NEU1 expression may 
determine vascular sites of atherogenesis, and based on our findings, we propose that this is partly mediated 
via Nrf2-dependent regulation of endothelial redox signalling. 
As reported previously [10], USS enhanced the expression of endogenous antioxidant defenses via Nrf2 
signaling but only in the presence of intact SIA. Functional nuclear accumulation of Nrf2 in response to 
USS is mediated by PI3K and downstream Akt and protein kinase C activity [7, 14], thus reduced Akt 
activation following SIA removal possibly attenuated Nrf2 responses to USS. Akt signaling also represses 
GSK3β activity [47], which is known to promote Nrf2 nuclear export [81] and its Keap-1 independent 
cytosolic degradation [82]. This may contribute to the diminished induction of Nrf2 nuclear accumulation 
by USS following SIA cleavage. Moreover, direct tethering of the Keap-1/Nrf2 complex on the outer 
mitochondrial membrane is postulated to maintain mitochondrial redox homeostasis [83], thus impaired 
Nrf2 activation in the absence of SIA has likely enhanced mitochondrial ROS accumulation in response to 
USS. In agreement with our findings, vascular ROS accumulation is observed in porcine femoral arteries 
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perfused with neuraminidase [26] and extracellular ROS levels are upregulated when EC are exposed to 
neuraminidase in the presence of a phagocytic stimulus [84]. Based on evidence that SIA can directly 
interact with H2O2 and •OH [85, 86], it is possible that the antioxidant defences conferred by SIA-mediated 
scavenging were diminished after removal with neuraminidase. Although neuraminidase does not disrupt 
the extracellular superoxide dismutase (ecSOD) [26] which is bound to the HS component of the GCX [87], 
in the latter study, ecSOD did not provide sufficient antioxidant defence in the absence of SIA. Our finding 
of diminished Nrf2-mediated antioxidant responses therefore represents a novel mechanistic link between 
SIA disruption and vascular redox imbalance.  
Enhanced oxidative stress as a result of endothelial desialylation with neuraminidase has profound 
implications for vascular tone regulation as it contributes to impaired NO-mediated vasodilation [26]. 
Although the pro-oxidant environment directly decreases NO bioavailability [88], SIA removal with 
neuraminidase also inhibits flow-mediated NO production [51] and reduces soluble guanylate cyclase 
activity ex vivo [25]. Our finding of reduced eNOS phosphorylation in EC treated with neuraminidase 
therefore implicates SIA in mechanotransduction of USS for NO-mediated vasomotor control. This is in 
line with previous reports of reduced eNOS Ser1177 [89] and Ser633 [90] phosphorylation following 
disruption of other key GCX components. In this study, neuraminidase did not affect the expression of the 
major GCX glycosaminoglycan HS, however removal of SIA can decrease the negative surface charge that, 
in turn, distorts GCX structure and possibly alters mechanical force transmission for intracellular signaling 
throughout the GCX layer [20].     
We also demonstrated for the first time that SIA cleavage with neuraminidase upregulates endothelial 
VCAM-1 expression. As attenuated Nrf2 signaling has been directly implicated in the pathogenesis of 
vascular inflammation, SIA disruption may additionally initiate proinflammatory events via redox 
dysregulation. SIA deterioration due to systemic inflammation [91] or cleavage by neuraminidase [60] 
promotes inflammatory cell trafficking on healthy vessels and desialylation of VCAM-1 enhances EC 
adhesiveness under laminar flow [92]. Additionally, Nrf2 knockout mice exhibit enhanced VCAM-1 
expression in normally atheroprotected aortic regions [9] and VCAM-1 levels are enhanced by Nrf2 
silencing in EC exposed to shear stress in vitro [93]. In the latter study this is partly alleviated by antioxidant 
treatment, therefore enhanced mitochondrial ROS observed in our study in the absence of SIA is likely to 
have contributed to NF-kB activation [94]. Enhanced VCAM-1 expression has been observed following 
endothelial Klf4 depletion [55] whereas overexpression of Klf2 and Klf4 attenuates NF-kB assembly and 
VCAM-1 promoter activation [55, 56]. Therefore, the interactions between SIA and the mechanosensitive 
transcription factors Klf2 and Klf4 are likely to protect against proinflammatory changes in arterial regions 
exposed to USS. 
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Perturbations in GCX underly EC dysfunction in vascular pathologies associated with oxidative stress such 
as diabetes, stroke, hypertension and atherosclerosis [95]. Moreover, the age-related decline in adaptive 
cellular responses to oxidative stress, especially blunting of vascular Nrf2 antioxidant signaling, plays a 
key role in the accumulation of oxidative modifications that contribute to macromolecular damage and 
inflammation in CVD [96]. Microvascular dysfunction has also been linked to age-related GCX decline 
[97], therefore therapeutic strategies that mitigate GCX deterioration are likely to reduce the risk and 
severity of CVD in ageing [98]. Notably, experimental restoration of SIA has been shown to be efficacious 
against atherosclerosis [99], obesity-related hypertension [100] and age-related renal microvascular 
dysfunction [101]. Furthermore, it was recently reported that GCX enhancement by the GAG supplement 
sulodexide activates Nrf2 signalling to confer cytoprotection against ischaemia-reperfusion injury [102]. 
Further studies are thus warranted to further elucidate interactions between GCX components in 
coordinating Nrf2-regulated antioxidant defences. In summary, our findings provide a novel insight into 
the molecular mechanisms by which the endothelial GCX maintains Nrf2-mediated redox homeostasis and 
highlights the therapeutic potential of targeting SIA metabolism to ameliorate vascular dysfunction in 
atherogenesis and age-related CVD.  
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Figure Legends 
Fig. 1. Differential effects of laminar and disturbed shear stress on SIA expression. HUVEC were 
exposed to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in static conditions for 24 or 48 
hours, as indicated. (A) Representative electron micrographs of the cross-sectional aspect of the luminal 
GCX stained with ruthenium red and Alcian blue. Twenty measurements of the luminal GCX depth were 
averaged from each cell and are expressed as mean ± S.D. (n=1 donor) from at least 10 different cells per 
condition. ***P<0.001 (Student’s t-test). L, channel lumen; N, nucleus. Scale bar=200nm. (B)  
Representative confocal images of the SIA component of the GCX stained with WGA-CFTM448A (red) in 
fixed cells. WGA mean cell intensity (MCI) was quantified in the x-y optical slices and normalized to the 
respective number of cell nuclei stained with DAPI (blue). Data represent mean ± S.E.M. (n=5 different 
donors). *P<0.05; **P<0.01 (1-way ANOVA). Scale bar=20μm. (C) Amount of free SIA in the 
conditioned culture media was assessed fluorometrically. Data are mean ± S.E.M. (n=6 different donors). 
**P<0.01; ***P<0.001 (1-way ANOVA). (D) Relative mRNA expression of the genes GNE, CMAS, 
SLC35A1 and NEU1 encoding enzymes involved in SIA biosynthesis, transport and cleavage was determined 
by real time-PCR and normalized to 5 reference genes. Data are expressed as fold change from respective 
mRNA levels in static culture and denote mean ± S.E.M. (n=4-5 different donors). *P<0.05; **P<0.01 (1-
way ANOVA).  
Fig. 2. Induction of Nrf2 signaling by USS depends on SIA integrity. (A) Representative immunoblot 
of HO-1 expression in HUVEC subjected to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in 
static culture for 48 h. Densitometric analysis of HO-1 levels is shown relative to β-actin. Data are mean ± 
S.E.M. (n=3 different donors). *P<0.05; **P<0.01; ***P<0.001 (1-way ANOVA). (B) EA.hy926 cells 
stably transduced with lentiviral particles containing Nrf2 silencing shRNA (LvNrf2), scrambled sequences 
(Scr) or left untransfected (Control) were exposed to USS (15 dyn cm-2) for 24 h. HO-1 expression was 
assessed by immunoblotting relative to β-actin. Data denote mean ± S.E.M. (n=3 independent experiments). 
*P<0.05 (2-way ANOVA). (C–D) Following SIA removal with neuraminidase (Neur., 2 U ml-1, 30 min), 
both control and Neur.-treated HUVEC cultures were exposed to USS (15 dyn cm-2) for 6 , 8 and 24 hours 
or immediately terminated (0 h), as indicated. (C) Representative confocal images of SIA stained with 
WGA-CFTM448A (red) in fixed HUVEC. WGA mean cell intensity (MCI) was quantified in the x-y optical 
slices and normalized to the number of cell nuclei stained with DAPI (blue). Data denote mean ± S.E.M. 
(n=3-6 different donors). *P<0.05; **P<0.01; ***P<0.001 (2-way ANOVA). Scale bar=20μm. (D). 
Protein expression and densitometric analyses of the Nrf2 targets HO-1, NQO1 and GCLM relative to β-
actin. Data denote mean ± S.E.M. (n=4-5 different donors). *P<0.05; **P<0.01; ***P<0.001 (2-way 
ANOVA).  
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Fig. 3. Effect of SIA cleavage on Nrf2 nuclear translocation and kinase activation by USS. HUVEC 
were incubated with neuraminidase (Neur., 2 U ml-1, 30 min) before exposure to USS (15 dyn cm-2) for the 
indicated time periods. (A) Representative images of Nrf2 cellular localization and nuclear-to-cytosolic 
fluorescence intensity ratio. Cell nuclei were stained with DAPI which was omitted for clarity. Data are 
mean ± S.E.M. (n=5 donors) of quantification analysis from at least 300 cells per condition. *P<0.05 (2-
way ANOVA). Scale bar=20μm. (B-D) Representative immunoblots and densitometric analyses of 
phosphorylation of Nrf2-S40 (B), Akt-S473 (C) and GSK3β-Y216 (D) relative to respective total protein 
and β-actin loading controls. Data denote mean ± S.E.M. (n=4-6 different donors). *P<0.05; **P<0.01 (2-
way ANOVA). 
Fig. 4. Endogenous NEU1 knockdown enhances Nrf2-mediated antioxidant signaling. EA.hy926 cells 
transduced with lentiviral particles either containing sialidase 1 (NEU1)  silencing shRNA (LvNEU1) or 
scrambled sequences (Scr) were exposed to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in 
static culture for 48 h. (A) Representative immunoblot and densitometric analysis of NEU1 expression in 
whole cell lysates presented relative to β-actin. Data denote mean ± S.E.M. (n=5 independent cultures). 
*P<0.05; ** P<0.01; ***P<0.001 (2-way ANOVA). (B) Representative fluorescence images of the SIA 
component of the GCX stained with WGA-CFTM448A (red) in fixed cells using an inverted epi-
fluorescence microscope. WGA mean cell intensity (MCI) was normalized to the respective number of cell 
nuclei stained with DAPI (blue). Data are expressed as mean ± S.E.M. (n=3 independent cultures). Scale 
bar=20μm. (C) Representative immunoblots and densitometric analyses of HO-1, NQO1 and GCLM 
expression in whole cell lysates presented relative to β-actin. Data denote mean ± S.E.M. (n=5 independent 
cultures). *P<0.05; ** P<0.01; ***P<0.001 (2-way ANOVA). 
Fig. 5. Effects of disturbed flow or SIA removal on mitochondrial ROS levels. (A) HUVEC were 
exposed to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in static conditions for 48 h. (B) 
HUVEC were treated with neuraminidase (Neur., 2 U ml-1, 30 min) before exposure to USS (15 dyn cm-2) 
for 1 h.  At the end of all treatments, cells were incubated with the mitochondrial ROS indicator MitoSOX 
Red and maintained in static culture (30 min) before fixation and imaging. Cell nuclei were co-stained with 
DAPI which was omitted for clarity. Representative images and quantification of mean fluorescence 
intensity normalized to the number of cell nuclei are shown. Data denote mean ± S.E.M. (n=4 different 
donors). *P<0.05; **P<0.01 (1 or 2-way ANOVA). Scale bar=50μm. 
Fig. 6. SIA cleavage attenuates eNOS phosphorylation by USS and induces VCAM-1. HUVEC were 
incubated with neuraminidase (Neur., 2 U ml-1, 30 min) before exposure to USS (15 dyn cm-2) for the 
indicated time points. (A-B) Representative immunoblots and densitometric analyses of eNOS 
phosphorylation at S1177 and S633 relative to β-actin and total eNOS levels. Data denote mean ± S.E.M. 
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(n=4-6 different donors). *P<0.05 (2-way ANOVA). (C) Representative immunoblot and densitometric 
analysis of VCAM1 expression relative to β-actin. Data denote mean ± S.E.M. (n=3 donors). *P<0.05, 
**P<0.01 (2-way ANOVA). (D) Representative images of p65 subunit cellular distribution (green) and 
quantification of nuclear-to-cytosolic fluorescence intensity in fixed cells. Cell nuclei were co-stained with 
DAPI which was omitted for clarity. Data denote mean ± S.E.M. (n=4 different donors) of fluorescence 
intensity values from at least 300 cells per condition. *P<0.05 (2-way ANOVA). Scale bar=20μm.  
Figure S1. Differential distribution of SIA in response to laminar and disturbed shear stress. HUVEC 
were exposed to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in static conditions for 48 h. 
Representative confocal images of the SIA component of the GCX stained with WGA-CFTM448A (red) and 
the cell nuclei stained with DAPI (blue) in fixed cells. The y- and x- volume reconstructions of the z-plane 
(20μm depth, inter-slice distance, 0.1μm) are shown around the main x-y panel for each condition. Images 
are representative of n=3 different donors. Scale bars: x-y=20μm, x-z=10μm, y-z=5μm. 
Fig. S2. Laminar shear enhances Nrf2 nuclear translocation and antioxidant enzyme expression in 
vitro. HUVEC were exposed to USS (15 dyn cm-2), OSS (±5 dyn cm-2, 1 Hz) or maintained in static 
conditions for 48 h. (A) Representative immunoblots and densitometric analyses of NQO1 and GCLM 
expression is shown relative to β-actin. Data denote mean ± S.E.M. (n=4-6 donors). *P<0.05; **P<0.01 (1-
way ANOVA). (B) Quantification of nuclear and cytoplasmic fluorescence intensity of Nrf2 in fixed cells. 
Data from at least 50 cells per condition are presented as mean ± S.E.M. (n=3 donors). *P<0.05; **P<0.01 
(1-way ANOVA). (C) EA.hy926 cells were either transduced with lentiviral particles containing Nrf2 
silencing shRNA (LvNrf2) or scrambled sequences (Scr) or left untransfected (Control). Whole cell Nrf2, 
NQO1 and GCLM protein expression relative to β-actin following application of USS (15 dyn cm-2) for 24 
h. Data denote mean ± S.E.M. (n=3 independent experiments). *P<0.05 (2-way ANOVA). 
Fig. S3. Neuraminidase selectively removes the SIA component of the GCX. HUVEC maintained in 
static culture were incubated with neuraminidase (Neur., 2 U ml-1, 30 min) and fixed cells were stained with 
(A) the anti-N-sulphated HS 10E4 epitope followed by an Alexa Fluor 568 secondary antibody (green) or 
(B) peanut lectin (PNA-CFTM568A) from Arachis hypogaea (green) that binds to subterminal β-galactose 
residues. Representative images of HS, PNA and cell nuclei stained with DAPI (blue). Data are expressed 
as mean cell intensity (MCI) normalized to the respective number of cell nuclei per FOV and represent 
mean ± S.E.M. (n=4 donors) of at least 50 cells per condition. **P<0.01 (Student’s t-test). Scale bar=20μm.  
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Fig. S4. SIA cleavage attenuates the induction of Klf2 and Klf4 by USS. HUVEC were incubated with 
neuraminidase (Neur., 2 U ml-1, 30 min) before exposure to USS (15 dyn cm-2) for the indicated time points. 
Representative immunoblots and densitometric analyses of Klf2 and Klf4 protein expression relative to β-









Table 1. List of primer sequences 
Gene                              Forward                                 Reverse 
KLF2 5΄-CGCTGAGTGAACCCATCCTG-3΄ 5΄-ATGAAGTCCAGCACGCTGTT-3΄ 
KLF4 5΄-GCCGCTCCATTACCAAGAG-3΄ 5΄-GTAATCACAAGTGTGGGTGGC-3΄ 
GNE 5΄-CACAGGCACAGGAATCGGT-3΄ 5΄-CCATTCCAGAGGCGTATGCT-3΄ 
CMAS 5΄-TCGTGAAGTGACCGAACCTC-3΄ 5΄-TTCCACCCTGCAAGTAACCC-3΄ 
SLC35A1 5΄-TTGTGACATTAGCTGGCGTCT-3΄ 5΄-GCAAGAAAGATGACAAACCAGACA-3΄ 
NEU1 5΄-GCACATCCAGAGTTCCGAGT-3΄ 5΄-CAGGGTTGCCAGGGATGAAT-3΄ 
Reference genes 
ACTB 5΄-CCAGAGGCGGTACAGGGAATAG-3΄ 5΄-CCAACCGCGAGAAGATGA-3΄ 
B2M 5΄-TTCTGGCCTGGAGGCTATC-3΄ 5΄-TCAGGAAATTTGACTTTCCATTC-3΄ 
RPL13A 5΄-GAGGCCCCTACCACTTCC-3΄ 5΄-AACACCTTGAGACGGTCCAG-3΄ 
SDHA 5΄-AGAAGCCCTTTGAGGAGCA-3΄ 5΄-CGATTACGGGTCTATATTCCAGA-3΄ 
TBP 5΄-GCTGGCCCATACTGATCTTT-3΄ 5΄-CTTCACACGCCAAGAAACAGT-3΄ 
Abbreviations: ACTB, β-actin; B2M, β-2-microglobulin; CMAS, cytidine monophosphate N-acetylneuraminic 
acid synthetase; GNE, glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; KLF2/4, 
krüppel-like factor 2/4; NEU1,  neuraminidase 1;  RPL13A, 60S ribosomal protein L13A; SDHA, succinate 
dehydrogenase complex subunit A; SLC35A1,  solute carrier family 35 member A1; TBP, TATA-box binding 
protein. 
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